Targeting the bacterium's metabolism could enable scientists to develop drugs that only affect H. pylori. Dr. Amieva's research focuses on the H. pylori bacterium. The constant inflammation associated with chronic ulcers that is the main symptom of an H. pylori infection is commonly associated with stomach cancers. Although the bacterium can, once identified, be treated with antibiotics, those antibiotics often lead to other gastrointestinal issues because they kill they do not differentiate between good and bad bacteria. Although patients with H. pylori-induced ulcers usually present with stomach pain, nausea, vomiting, and even bleeding and anemia; however, most individuals with H. pylori infections do not experience any symptoms at all.
Summary Researchers have known that intestinal bacteria, known as gut microbiota, can affect the risk of complications from bone marrow transplantation such as graft versus host disease. Developing a way to safely transplant bone marrow represents one of the great success stories in treating blood cancers such as leukemia and lymphoma. Researchers have known for decades that the makeup of bacteria in the gastrointestinal tract can impact how a patient fares following a transplant. Patients harboring this bacterial group, made up primarily of the bacterium Eubacterium limosum, had their cancer come back at a significantly lower rate. A new MSK study found an association between the presence of a bacterial group and a lower risk that the patient's leukemia or lymphoma will return after the transplant.
collected by :Lucy William
No comments:
Post a Comment